FDA — authorised 3 December 1954
- Application: NDA009048
- Marketing authorisation holder: VALEANT PHARM INTL
- Local brand name: 8-MOP
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 UVADEX in United States
FDA authorised UVADEX on 3 December 1954
Marketing authorisations
FDA
- Status: approved
UVADEX in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is UVADEX approved in United States?
Yes. FDA authorised it on 3 December 1954; FDA has authorised it.
Who is the marketing authorisation holder for UVADEX in United States?
VALEANT PHARM INTL holds the US marketing authorisation.